179 related articles for article (PubMed ID: 32536690)
21. A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia.
Samuels AL; Beesley AH; Yadav BD; Papa RA; Sutton R; Anderson D; Marshall GM; Cole CH; Kees UR; Lock RB
Blood Cancer J; 2014 Aug; 4(8):e232. PubMed ID: 25083816
[TBL] [Abstract][Full Text] [Related]
22. Late relapse after allogeneic bone marrow transplantation for Philadelphia-positive acute lymphoblastic leukaemia.
Mughal T; Morleda J; Goldman J
Acta Haematol; 1993; 89(3):149-51. PubMed ID: 8362603
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Dopfer R; Henze G; Bender-Götze C; Ebell W; Ehninger G; Friedrich W; Gadner H; Klingebiel T; Peters C; Riehm H
Blood; 1991 Nov; 78(10):2780-4. PubMed ID: 1824271
[TBL] [Abstract][Full Text] [Related]
24. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
Yetgin S; Cetin M
Leuk Lymphoma; 2003 Mar; 44(3):489-95. PubMed ID: 12688320
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of chemotherapy combined with bortezomib for two cases of relapsed/refractory acute lymphoblastic leukemia].
Keino D; Ohyama R; Ashikaga T; Morimoto M; Yamashita A; Kondoh K; Kinoshita A
Rinsho Ketsueki; 2014 Mar; 55(3):327-33. PubMed ID: 24681936
[TBL] [Abstract][Full Text] [Related]
26. A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG-asparaginase, and doxorubicin.
Trucco M; Barredo JC; Goldberg J; Leclerc GM; Hale GA; Gill J; Setty B; Smith T; Lush R; Lee JK; Reed DR
Pediatr Blood Cancer; 2018 Sep; 65(9):e27224. PubMed ID: 29856514
[TBL] [Abstract][Full Text] [Related]
27. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
[TBL] [Abstract][Full Text] [Related]
28. The frequency of micronuclei in bone-marrow erythroblasts during the treatment of childhood acute lymphoblastic leukaemia.
Slavotinek A; Thomson A; Eynaud P; Perry P; Steel CM; Eden OB
Mutat Res; 1993 Sep; 303(1):11-18. PubMed ID: 7690901
[TBL] [Abstract][Full Text] [Related]
29. [Anemia and recurrences in acute lymphoblastic leukemia in children after the treatment and the frequency of the erythroblasts with micronuclei].
Rytwiński K; Sońta-Jakimczyk D; Konopacka M; Ciechanowska U
Acta Haematol Pol; 1992; 23(2):95-9. PubMed ID: 1488866
[TBL] [Abstract][Full Text] [Related]
30. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Abshire TC; Pollock BH; Billett AL; Bradley P; Buchanan GR
Blood; 2000 Sep; 96(5):1709-15. PubMed ID: 10961868
[TBL] [Abstract][Full Text] [Related]
31. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Henze G; v Stackelberg A; Eckert C
Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
[TBL] [Abstract][Full Text] [Related]
32. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Sadowitz PD; Smith SD; Shuster J; Wharam MD; Buchanan GR; Rivera GK
Blood; 1993 Feb; 81(3):602-9. PubMed ID: 8427957
[TBL] [Abstract][Full Text] [Related]
33. RALLE pilot: response-guided therapy for marrow relapse in acute lymphoblastic leukemia in children.
Saarinen-Pihkala UM; Parto K; Riikonen P; Lähteenmäki PM; Békàssy AN; Glomstein A; Möttönen M
J Pediatr Hematol Oncol; 2012 May; 34(4):263-70. PubMed ID: 22246158
[TBL] [Abstract][Full Text] [Related]
34. [Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
Tacik J; Skoczeń S; Armata J; Balwierz W
Przegl Lek; 1992; 49(3):102-3. PubMed ID: 1438896
[No Abstract] [Full Text] [Related]
35. Relapses after termination of therapy of acute lymphoblastic leukemia in children.
Ochocka M; Matysiak M; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M; Michalewska D
Acta Paediatr Jpn; 1993 Oct; 35(5):377-81. PubMed ID: 8256619
[TBL] [Abstract][Full Text] [Related]
36. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
Morland BJ; Shaw PJ
Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
[TBL] [Abstract][Full Text] [Related]
37. Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study.
Buchanan GR; Rivera GK; Boyett JM; Chauvenet AR; Crist WM; Vietti TJ
Blood; 1988 Oct; 72(4):1286-92. PubMed ID: 3167209
[TBL] [Abstract][Full Text] [Related]
38. Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance.
Yeo KK; Gaynon PS; Fu CH; Wayne AS; Sun W
J Pediatr Hematol Oncol; 2016 Jul; 38(5):345-9. PubMed ID: 27352191
[TBL] [Abstract][Full Text] [Related]
39. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
[TBL] [Abstract][Full Text] [Related]
40. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).
Chessells JM; Cornbleet M
Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
